Jessica Pougoue Ketchemen
4PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 22, 2025
Preclinical characterization of 3p-C-DEPA<sub>-NCS</sub> and 3p-C-DEPA<sub>-TFP</sub>-PEG<sub>4</sub> as potential Actinium-225 bifunctional chelators using DOTA<sub>-NCS</sub> and macropa<sub>-NCS</sub> as benchmarks.Jessica Pougoue Ketchemen, Stephen Ahenkorah, Emmanuel Nwangele
|May 28, 2025
Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering.Olga Bednova, Jessica Pougoue Ketchemen, Hazem Mslati
|Mar 24, 2025
An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Antitumor Responses in KRAS- and BRAF-Mutant Colorectal Cancer.Anjong Florence Tikum, Nikita W Henning, Jessica Pougoue Ketchemen
|Dec 13, 2024
Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody-Drug Radioconjugate.Jessica Pougoue Ketchemen, Fabrice Ngoh Njotu, Hanan Babeker
Pageof 1
Frequent Collaborators
3 joint publications
Humphrey Fonge
2 joint publications
Fabrice Ngoh Njotu
2 joint publications
Hanan Babeker
2 joint publications
Alissar Monzer
2 joint publications
Emmanuel Nwangele
2 joint publications
Anjong Florence Tikum
2 joint publications
Nikita W Henning
2 joint publications
Alireza Doroudi
1 joint publications
Thomas Cardinaels
1 joint publications
Sarah Frye
